Jeffrey Berger is the Charles Aden Poindexter Associate Professor of Medicine and Surgery at New York University School of Medicine, and is the Director of the Center for the Prevention of Cardiovascular Disease. Dr. Berger is the Principal Investigator of an independent NIH-funded research program investigating the mechanistic role of platelets across cardiovascular and inflammatory diseases. His research program is investigating the contribution of platelet activity and coding and non-coding RNA to high risk phenotypes, including atherosclerosis, thrombosis, peripheral artery disease, coronary artery disease, lupus, HIV and other inflammatory diseases. Dr. Berger’s research spans the clinical spectrum including leading large multinational randomized trials investigating risk stratification and pharmacotherapies aimed at decreasing cardiovascular events. Dr. Berger have a proven track record of leading multidisciplinary translational clinical projects, bridging both basic science and clinical research. As a principal investigator, Dr. Berger has a consistent record of accomplishment of extramural funding and published over 275 peer-reviewed articles.